How to achieve a near 100% cure rate for H. pylori infection in peptic ulcer patients: A personal viewpoint

Journal of Clinical Gastroenterology

Volumn 22, Issue 4, 1996, Pages 313-316

  De Boer, W A ^a  

^a ST ANNA HOSPITAL   (Netherlands)

Author keywords

Helicobacter pylori; Quadruple therapy; Triple therapy

Indexed keywords

AMOXICILLIN; BISMUTH DERIVATIVE; CLARITHROMYCIN; FAMOTIDINE; LANSOPRAZOLE; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; OMEPRAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PATIENT COMPLIANCE; PEPTIC ULCER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BISMUTH; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PEPTIC ULCER;

EID: 0030049478     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199606000-00016     Document Type: Article

References (28)

1. National Institutes of Health Consensus Conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
2. Tytgat GNJ. Treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-68.
3. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89: S116-28.
4. Witte Cl. Is vagotomy and gastrectomy still justified for gastroduodenal ulcer? J Clin Gastroenterol 1995;20:2-3.
5. de Boer WA, Tytgat GNJ. The best therapy for Helicobacter pylori infection: Should efficacy or side effect profile determine our choice? Scand J Gastroenterol 1995;30:401-7.
6. de Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol 1995;7:1189-94.
7. Thys JC, van Zwet AA, Moolenaar W, Wolfhagen MJHM, ten Bokkel Huinink J. Triple therapy versus amoxicillin plus omeprazole for the treatment of Helicobacter pylori infection. Am J Gastroenterol 1996;91:93-7.
8. Archimandritis A, Balatsos V, Delis V, Mentis A, Kastanas K, Scandalis N. Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine: a 12 month follow-up. J Clin Gastroenterol 1995;20:12-6.
9. Wilhelmsen I, Weberg R, Berstad K, Hausken T, Hundal O, Berstad A. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease. Hepato-Gastroenterol 1994;41:43-7.
10. de Boer WA, Driessen WMM, Potters HVPJ, Tytgat GNJ. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994;89: 1993-7.
11. Seppala K, Farkkilla M, Nuutinen H, et al. Triple therapy of Helicobacter pylori infection in peptic ulcer: a 12 month follow-up study of 93 patients. Scand J Gastroenterol 1992;27:973-6.
12. Thys JC, van Zwet AA, Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. Scand J Gastroenterol 1993;28:934-8.
13. Borody TJ, Brandi S, Andrews P, Ferch N, Jankiewicz E, Hyland L. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:33-8.
14. Schulz TB, Kjellevold O, Roynstrand E, Rolke H. Triple therapy in a central hospital [Abstract no 1503]. Presented at the United European Gastroenterology Week, Oslo, June 25-29, 1994.
15. Rodionoff P, Hyland L, Ostapowicz N, et al. Triple therapy for Helicobacter pylori eradication: 1, 2 or 4 weeks? [Abstract PP938]. Presented at the World Congresses of Gastroenterology, Sydney, Australia, August 26-31, 1990.
16. Xia H, Daw MA, Sant S, Beattie S, Keane CT, O'Morain CA. Clinical efficacy of triple therapy in Helicobacter pylori associated duodenal ulcer. Eur J Gastroenterol Hepatol 1993;5:141-4.
17. Noach LA, Bertola MA, Schwartz MP, Rauws EAJ, Tytgat GNJ. Treatment of H. pylori infection: an evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 1994;6:585-91.
18. Sung JJY, Chung SCS, Ling TKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332:139-42.
19. de Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817-20.
20. Borody TJ, Andrews P, Fracchia G, Brandi S, Shortis NP, Bea H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995;37:477-81.
21. Hosking SW, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet 1994;343:508-10.
22. Hosking SW, Ling TKW, Yung MY, et al. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. Br Med J 1992;305:502-4.
23. Tucci A, Corinaldesi R, Stanghellini V, et al. One day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci 1993;38:1670-3.
24. de Boer WA, Driessen WMM, Tytgat GNJ. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:633-8.
25. Bazzoli F, Zagari RM, Fossi S, et al. Short term low-dose triple therapy for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-7.
26. de Boer WA, Tytgat GNJ. Ninety percent cure: Which anti-Helicobacter therapy can achieve this treatment goal? [Editorial]. Am J Gastroenterol 1995;90:1381-2.
27. Borody TJ. Possibilities for Helicobacter pylori suppression/ eradication. Eur J Gastroenterol Hepatol 1992;4(suppl 2): S37-40.
28. Lamb GC, Green SS, Heron J. Can physicians warn patients of potential side effects without fear of causing those side effects? Arch Intern Med 1994;154:2753-6.